10 HUDSON YARDS, 37TH FLOOR
NEW YORK NY 10001
Business Phone: 646-747-1000
• NEW YORK, NY How do I update this listing?
Intercept Pharmaceuticals is based out of New York. Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat chronic liver diseases utilizing proprietary bile acid chemistry. It primarily develops obeticholic acid, a bile acid analog and farnesoid X receptor (FXR) agonist that is in Phase III clinical trials for the treatment of primary biliary cirrhosis; in Phase IIa clinical trials to treat portal hypertension; in Phase IIb clinical trials for the nonalcoholic steatohepatitis treatment; and in Phase IIa trials for the treatment of bile acid diarrhea.Whalewisdom has at least 1 13G filings, and 365 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-09-04. The notice included securities offered of Equity